Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
30 Apr 24
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
19 Apr 24
NT 10-Q
Notice of late quarterly filing
8 Apr 24
8-K
Results of Operations and Financial Condition
1 Apr 24
8-K
Changes in Registrant's Certifying Accountant
26 Mar 24
8-K
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
20 Mar 24
8-K
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
20 Mar 24
10-K
2023 FY
Annual report
19 Mar 24
8-K
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
16 Feb 24
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
12 Jan 24
NT 10-Q
Notice of late quarterly filing
10 Jan 24
8-K
Entry into a Material Definitive Agreement
5 Jan 24
8-K
Regulation FD Disclosure
20 Nov 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
31 Oct 23
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
18 Oct 23
NT 10-Q
Notice of late quarterly filing
10 Oct 23
8-K
Results of Operations and Financial Condition
31 Aug 23
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
22 Aug 23
NT 10-K
Notice of late annual filing
14 Aug 23
EFFECT
Notice of effectiveness
12 Jun 23
424B3
Prospectus supplement
9 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
S-1/A
IPO registration (amended)
6 Jun 23
10-Q
2023 Q3
Quarterly report
2 Jun 23
8-K
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
1 Jun 23
8-K
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
22 May 23
8-K
Departure of Directors or Certain Officers
2 May 23
8-K
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
14 Apr 23
UPLOAD
Letter from SEC
14 Apr 23
NT 10-Q
Notice of late quarterly filing
10 Apr 23
S-1
IPO registration
6 Apr 23
S-8
Registration of securities for employees
6 Apr 23
8-K
Regulation FD Disclosure
6 Apr 23
8-K/A
Financial Statements and Exhibits
27 Mar 23
8-K
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
16 Mar 23
10-Q
2023 Q2
Quarterly report
16 Mar 23
10-K/A
2022 FY
Annual report (amended)
16 Mar 23
8-K
Departure of Directors or Certain Officers
3 Mar 23
8-K
Entry into a Material Definitive Agreement
7 Feb 23
Latest ownership filings
SC 13D/A
22NW Fund, LP
29 Feb 24
SC 13G/A
DIMENSIONAL FUND ADVISORS LP
9 Feb 24
4
Joshua Schechter
2 Feb 24
4
Nathaniel Calloway
2 Feb 24
4
NELSON OBUS
2 Feb 24
4
JEFFREY L EDWARDS
2 Feb 24
4
Raymond H Diradoorian
2 Feb 24
4
LOVAS KATRINA HOUDE
2 Feb 24
4
Craig A. Barbarosh
2 Feb 24
4
John D Morberg
22 Jan 24
4
Nathaniel Calloway
10 Jan 24
SC 13D/A
Legion Partners Asset Management, LLC
4 Jan 24
SC 13D/A
Cove Street Capital, LLC
15 Aug 23
SC 13G/A
BlackRock Inc.
7 Jul 23
SC 13G
Greenhaven Road Investment Management, L.P.
30 Jun 23
SC 13D/A
22NW Fund, LP
28 Jun 23
4
Christopher S Kiper
5 Jun 23
4
Craig A. Barbarosh
5 Jun 23
4
Raymond H Diradoorian
5 Jun 23
4
James G Hall
5 Jun 23
4
John D Morberg
5 Jun 23
4
Nathaniel Calloway
5 Jun 23
4
JEFFREY L EDWARDS
5 Jun 23
4
LOVAS KATRINA HOUDE
5 Jun 23
4
NELSON OBUS
5 Jun 23
4
Joshua Schechter
5 Jun 23
4
Raymond H Diradoorian
1 Jun 23
4
NELSON OBUS
1 Jun 23
4
JEFFREY L EDWARDS
1 Jun 23
4
LOVAS KATRINA HOUDE
1 Jun 23
4
Craig A. Barbarosh
1 Jun 23
4
Joshua Schechter
1 Jun 23
SC 13D/A
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I
16 Mar 23
SC 13D/A
WYNNEFIELD PARTNERS SMALL CAP VALUE LP
7 Mar 23
SC 13G/A
ISZO CAPITAL LP
14 Feb 23
SC 13G/A
DIMENSIONAL FUND ADVISORS LP
10 Feb 23
4
Christopher S Kiper
2 Feb 23
4
JEFFREY L EDWARDS
2 Feb 23
4
LOVAS KATRINA HOUDE
2 Feb 23
4
NELSON OBUS
2 Feb 23